Brazilian Health Regulator Denounces China’s Lack of Transparency in Vaccine Emergency Use

Brazilian health regulator Anvisa said on Tuesday morning that China’s health authorities are not being transparent in their authorization of COVID-19 vaccines for emergency use.

Brazilian health regulator Anvisa said on Tuesday morning that China’s health authorities are not being transparent in their authorization of COVID-19 vaccines for emergency use.

“Brazil is the international leader in the evaluation process for CoronaVac. The vaccine has had an emergency use authorization in China since June of this year. The Chinese criteria for granting emergency use authorization are not transparent, and there is no available information about the criteria currently in use by Chinese authorities to make these decisions” Anvisa said in a statement on its website.

Brazilian President Jair Bolsonaro has repeatedly cast doubt on the CoronaVac vaccine being developed by China’s Sinovac Biotech.

Meanwhile, Sao Paulo Governor Joao Doria, who is one of the main opposition leaders in Brazil, said the state expected to start vaccinating its residents in January, though Brazil’s most populous state will not be able to use CoronaVac until it is approved by the health regulator.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.